We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01588730
Recruitment Status : Terminated
First Posted : May 1, 2012
Last Update Posted : August 12, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to compare the Ankle Dorsiflexion Dynasplint System (DS) to static night splint for the reduction of pain from Plantar Fasciitis (Fasciopathy).

Condition or disease Intervention/treatment Phase
Plantar Fasciitis Plantar Fasciopathy Device: Ankle Dorsiflexion Dynasplint Procedure: Commercially Available Static Night splint Phase 4

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 26 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy
Study Start Date : June 2011
Estimated Primary Completion Date : June 2015
Arms and Interventions

Arm Intervention/treatment
Experimental: Dynasplint
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn at night while sleeping (6-8 hours).
Device: Ankle Dorsiflexion Dynasplint
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn at night while sleeping (6-8 hours) and, this does not affect activities of daily living
Active Comparator: Static Splint
The control group will be treated with a static splint for a minimum of 6 4 hours each night while sleeping with the end goal of 6-8 hours.
Procedure: Commercially Available Static Night splint
A commericially avilable static night splint will be worn for 4-6 hours during rest.


Outcome Measures

Primary Outcome Measures :
  1. FFI score [ Time Frame: 16 weeks ]
    The primary outcome measure will be difference between the pretreatment and two month cumulative Foot Function Index (PS-FFI) score


Secondary Outcome Measures :
  1. Pain subscale and SROM questionnaire [ Time Frame: 2, 4 and 12 months ]

    Secondary outcome measures will include two month, four month, and twelve month overall heel pain reduction measured by the responses to the following questionnaires:

    1. Pain subscale of the validated Foot Function Index (PS-FFI)
    2. A patient-relevant outcome measures (SROM) questionnaire that included generic and condition -specific outcome measures related to pain, function, and satisfaction with the treatment outcome.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients will have had a history of at least 3 consecutive months of plantar heel pain well-localized to the plantar fascia.
  • All patients will have failed an initial treatment of non-weight bearing plantar and Achilles stretching.
  • Diagnosis will be confirmed by physical examination by a single physician (JPF) with a typical point of maximum tenderness over the medial tubercle of the calcaneus

Exclusion Criteria:

  • rheumatoid arthritis
  • local infection
  • pregnancy
  • patients with tumors
  • unresolved fractures
  • severe peripheral vascular disease
  • history of prior plantar fascia surgery
  • history of plantar fascia rupture
  • age <18 years
  • recent ( within 6 weeks) steroid injection
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01588730


Locations
United States, Pennsylvania
SUN Orthopaedic Group Inc
Lewisburg, Pennsylvania, United States, 17837
Sponsors and Collaborators
Dynasplint Systems, Inc.
Investigators
Principal Investigator: John Furia, MD SUN Orthopaedic Group Inc
More Information

Publications:
Furia JP, Rompe JD .Extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis and Achilles tendinopathy.Curr Opin Orthop 2007;18:102-111

Responsible Party: Dynasplint Systems, Inc.
ClinicalTrials.gov Identifier: NCT01588730     History of Changes
Other Study ID Numbers: Dyna-PF 2011
First Posted: May 1, 2012    Key Record Dates
Last Update Posted: August 12, 2013
Last Verified: August 2013

Keywords provided by Dynasplint Systems, Inc.:
PF
Dynasplint
ADFD
AFD
Plantar Fasciitis
plantar Fasciopathy

Additional relevant MeSH terms:
Fasciitis
Fasciitis, Plantar
Musculoskeletal Diseases
Foot Diseases